|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Continuing operations | |||||
| Revenue | |||||
| Cost of sales | |||||
| Gross profit (loss) | |||||
| Research and development expenses | |||||
| Selling and general administrative expenses | |||||
| Impairment gains (losses) on trade receivables, contract assets, and other investments | |||||
| Other income | |||||
| Other expenses | |||||
| Operating result | |||||
| Finance income | |||||
| Finance expenses | |||||
| Net finance result | |||||
| Result before tax | |||||
| Income tax benefits (expenses) | |||||
| Result for the period | |||||
| Items that are or may be reclassified subsequently to profit or loss | |||||
| Foreign operations – foreign currency translation differences | |||||
| Other comprehensive income (loss) for the period, net of tax | |||||
| Total comprehensive income (loss) for the period | |||||
| Profit (loss) attributable to: | |||||
| Shareholders of the parent | |||||
| Total comprehensive income (loss) attributable to: | |||||
| Shareholders of the parent | |||||
| Diluted (in Euro per share and Dollars per share) | |||||
| Basic (in Euro per share and Dollars per share) | |||||
Loading...